Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae
- PMID: 10025478
- DOI: 10.1093/oxfordjournals.aje.a009820
Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae
Abstract
The serovars of Neisseria gonorrhoeae that are predominant in a community change over time, a phenomenon that may be due to the development of immunity to repeat infection with the same serovar. This study evaluated the epidemiologic evidence for serovar-specific immunity to N. gonorrhoeae. During a 17-month period in 1992-1994, all clients of a sexually transmitted disease clinic in rural North Carolina underwent genital culture for N. gonorrhoeae. Gonococcal isolates were serotyped according to standard methods. Odds ratios for repeat infection with the same serovar versus any different serovar were calculated on the basis of the distribution of serovars in the community at the time of reinfection. Of 2,838 patients, 608 (21.4%; 427 males and 181 females) were found to be infected with N. gonorrhoeae at the initial visit. Ninety patients (14.8% of the 608) had a total of 112 repeat gonococcal infections. Repeat infection with the same serovar occurred slightly more often than would be expected based on the serovars prevalent in the community at the time of reinfection, though the result was marginally nonsignificant (odds ratio = 1.5, 95% confidence interval 1.0-2.4; p = 0.05). Choosing partners within a sexual network may increase the likelihood of repeat exposure to the same serovar of N. gonorrhoeae. Gonococcal infection did not induce evident immunity to reinfection with the same serovar.
Similar articles
-
Serovar specific immunity to Neisseria gonorrhoeae: does it exist?Genitourin Med. 1995 Dec;71(6):367-9. doi: 10.1136/sti.71.6.367. Genitourin Med. 1995. PMID: 8566975 Free PMC article.
-
Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.J Clin Invest. 1989 May;83(5):1472-6. doi: 10.1172/JCI114040. J Clin Invest. 1989. PMID: 2496142 Free PMC article.
-
Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.J Clin Invest. 1993 Jan;91(1):339-43. doi: 10.1172/JCI116190. J Clin Invest. 1993. PMID: 8423230 Free PMC article.
-
Human Immune Responses and the Natural History of Neisseria gonorrhoeae Infection.Front Immunol. 2019 Feb 19;9:3187. doi: 10.3389/fimmu.2018.03187. eCollection 2018. Front Immunol. 2019. PMID: 30838004 Free PMC article. Review.
-
Serological classification of Neisseria gonorrhoeae. Clinical and epidemiological applications.Antonie Van Leeuwenhoek. 1987;53(6):375-80. doi: 10.1007/BF00415490. Antonie Van Leeuwenhoek. 1987. PMID: 3130775 Review.
Cited by
-
Phenotypic and genotypic analyses of Neisseria gonorrhoeae isolates that express frequently recovered PorB PIA variable region types suggest that certain P1a porin sequences confer a selective advantage for urogenital tract infection.Infect Immun. 2008 Aug;76(8):3700-9. doi: 10.1128/IAI.00265-08. Epub 2008 Jun 9. Infect Immun. 2008. PMID: 18541655 Free PMC article.
-
Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.Epidemiol Infect. 2018 Feb;146(3):333-338. doi: 10.1017/S0950268818000092. Epub 2018 Feb 1. Epidemiol Infect. 2018. PMID: 29386078 Free PMC article.
-
Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.Vaccine. 2008 Oct 23;26(45):5741-51. doi: 10.1016/j.vaccine.2008.08.020. Epub 2008 Aug 30. Vaccine. 2008. PMID: 18762223 Free PMC article.
-
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.Vaccine. 2020 Jun 9;38(28):4362-4373. doi: 10.1016/j.vaccine.2020.02.073. Epub 2020 Apr 28. Vaccine. 2020. PMID: 32359875 Free PMC article.
-
Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.J Infect Dis. 2021 Aug 16;224(12 Suppl 2):S96-S102. doi: 10.1093/infdis/jiaa766. J Infect Dis. 2021. PMID: 34396399 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical